LONDON--(BUSINESS WIRE)--Technavio has announced their latest drug pipeline analysis report on axillary hyperhidrosis. The report includes a detailed analysis of the pipeline molecules under ...

DelveInsight’s, “Primary Axillary Hyperhidrosis – Pipeline Insight, 2025,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Primary Axillary Hyperhidrosis pipeline ...

Eccrine sweat glands—concentrated in the scalp, axillae, inguinal folds, and acral skin—function to maintain normal thermal homeostasis and, to a lesser extent, eliminate toxins and drug metabolites.

Please provide your email address to receive an email when new articles are posted on . Sofdra (sofpironium) gel 12.45% is the first and only chemical entity for primary axillary hyperhidrosis. The ...

Sofpironium bromide indirectly reduces the rate of sweating by preventing the stimulation of acetylcholine receptors that are located on sweat glands. The Food and Drug Administration (FDA) has ...

Please provide your email address to receive an email when new articles are posted on . Treatment with sofpironium bromide gel reduced the severity of primary axillary hyperhidrosis in a cohort of ...

Background: Recent studies demonstrate that botulinum toxin type A (BTX-A) decreases palmar hyperhidrosis. Objective: To evaluate the efficacy and safety of BTX-A for palmar hyperhidrosis. Methods: ...

The International Hyperhidrosis Society has updated its clinical practice guidelines to include topical anticholinergic cloths as a first- or second-line treatment option for certain patients with ...

Sofpironium bromide is a structural analogue of glycopyrrolate, an anticholinergic agent. Positive topline results were announced from 2 identical phase 3 studies evaluating sofpironium bromide in ...

Hyperhidrosis most commonly affects the armpits, followed by the palms of the hands and the soles of the feet. Impairment of quality of life differs based on where primary hyperhidrosis manifests on ...

Run a mile in the heat of the summer and you may get a sense of what some people with excessive sweating deal with every day. Fortunately, there will soon be a new treatment option available. The FDA ...

"Primary Axillary Hyperhidrosis Pipeline 2025"DelveInsight's,“Primary Axillary Hyperhidrosis – Pipeline Insight, 2025,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs ...